Home » Topics » Disease categories and therapies » Immune

Immune
RSS

MedImmune and Pasteur Merieux Connaught develop second-generation Lyme disease vaccine

Dec. 3, 1998

No Comments

CPMP issues positive opinion for E.U. approval of Zenapax

Dec. 2, 1998

No Comments

U.S. patent issued for Maxim's MaxVax technology

Dec. 2, 1998

No Comments

Abbott purchases additional La Jolla stock

Dec. 1, 1998

No Comments

OraVax files IND for colitis vaccine

Nov. 30, 1998

No Comments

North American Vaccine continues product launch of Certiva in U.S.

Nov. 26, 1998

No Comments

Positive clinical data supports Siga's unique vaccine delivery system

Nov. 25, 1998

No Comments

Chiron reports phase II results of novel Meningococcus C vaccine trial

Nov. 24, 1998

No Comments

Thalidomide analogue CC-3052 is more active, less toxic than parent drug

Nov. 23, 1998

No Comments

Phase II data demonstrate efficacy of Avant's rotavirus vaccine

Nov. 23, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Immune
RSS

MedImmune and Pasteur Merieux Connaught develop second-generation Lyme disease vaccine

CPMP issues positive opinion for E.U. approval of Zenapax

U.S. patent issued for Maxim's MaxVax technology

Abbott purchases additional La Jolla stock

OraVax files IND for colitis vaccine

North American Vaccine continues product launch of Certiva in U.S.

Positive clinical data supports Siga's unique vaccine delivery system

Chiron reports phase II results of novel Meningococcus C vaccine trial

Thalidomide analogue CC-3052 is more active, less toxic than parent drug

Phase II data demonstrate efficacy of Avant's rotavirus vaccine

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Ionis notches Arrowhead win; Tryngolza cleared for FCS

Promise Bio raises $8.3M for immune-mediated diseases platform

Immune RSS

Immune
RSS